Clinical Trials Browser

Phase 2 × amatuximab × Thoracic × Clear all

NCT00738582 2022-09-22

Amatuximab

Phase 2 Completed

89 enrolled 12 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02357147 2020-03-17

ARTEMIS

Phase 2 Terminated

124 enrolled 10 charts

Other solid neoplasmThoracic

Severe combined immunodeficiency with sensitivity to ionizing radiation, Mesothelioma, Malignant